7 Stocks Trending With Monster Volume

Professional traders running mutual funds and hedge funds don't just look at a stock's price moves, they track big changes in volume activity. Often, when above-average volume moves into a stock, it precedes a large spike in volatility.

Major moves in volume can signal unusual activity, such as insider buying or selling--or buying or selling by "superinvestors."

These types of traders like to get in well before a bigger trend, so it's always a smart move to monitor unusual volume. That said, remember to combine trend and price action with unusual volume. Put them all together to help you decipher the next big trend for any stock.

Jim Cramer sat down with four market experts to talk about how to play the Trump tax plan, the administration's impact on the dollar, commodities and more. Click here to check out their recommendations.

With that in mind, let's take a look at several stocks rising on unusual volume recently.

MyoKardia

  • Wednesday's Volume: 426,000
  • Three-Month Average Volume: 101,385
  • Volume % Change: 351%

From a technical perspective, MyoKardia (MYOK) ripped sharply higher right off its 20-day moving average of $12.25 a share and back above its 50-day moving average of $12.55 a share with big volume. This high-volume spike is now pushing this stock within range of triggering a big breakout trade.

Traders should now look for long-biased trades in MyoKardia, as long as it's trending above its 20-day at $12.25 or above more support at $11.80, and then once it sustains a move or close above those breakout levels with volume near or above 101,385 shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major resistance levels at $14.50 to $15, or even its 200-day moving average of $15.27 a share

Intra-Cellular Therapies

  • Wednesday's Volume: 2.66 million
  • Three-Month Average Volume: 544,082
  • Volume % Change: 467%

From a technical perspective, Intra-Cellular Therapies (ITCI) ripped sharply higher back above both its 20-day moving average of $13.55 a share and its 50-day moving average of $14.45 a share with monster volume. This high-volume move is now quickly pushing this stock within range of triggering a big breakout trade.

Traders should now look for long-biased trades in Intra-Cellular Therapies, as long as it's trending above its 20-day at $13.55, and then once it sustains a move close or above those breakout levels with volume near or above 544,082 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major resistance level at $17.59 a share. Any high-volume move above $17.59 will then give this stock a chance to run into its previous gap-down-day zone from last September that started near $42 a share.

Fiesta Restaurant Group

  • Wednesday's Volume: 1.26 million
  • Three-Month Average Volume: 341,252
  • Volume % Change: 293%

From a technical perspective, Fiesta Restaurant Group (FRGI) spiked big to the upside right above its recent low of $19.40 with strong volume. This high-volume bump higher is now quickly pushing this stock within range of triggering a breakout trade.

Traders should now look for long-biased trades in Fiesta Restaurant Group, as long as it's trending above that recent low of $19.40, and then once it sustains a move or close above those breakout levels with volume near or above 341,252 shares. If that breakout triggers soon, then this stock will set up to re-fill some of its previous gap-down-day zone that started near $25 a share.

Veeva Systems

  • Wednesday's Volume: 4.03 million
  • Three-Month Average Volume: 854,462
  • Volume % Change: 306%

From a technical perspective, Veeva Systems (VEEV) spiked sharply back above both its 50-day moving average of $43.04 a share and its 20-day moving average of $43.77 a share with strong volume. This high-volume jump managed to push this stock into breakout territory, above some resistance at $44.74 a share. Market players should now look for a continuation move higher if Veeva Systems manages to clear some resistance at $46 to $46.50 with high volume.

Traders should now look for long-biased trades in Veeva Systems, as long as it's trending above its 50-day at $43.04, and then once it sustains a move or close above $46 to $46.50 with volume near or above 854,462 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its 52-week high at $47.95 a share.

Akorn

  • Wednesday's Volume: 7.24 million
  • Three-Month Average Volume: 1.63 million
  • Volume % Change: 383%

From a technical perspective, Akorn (AKRX) ripped sharply higher back above both its 20-day moving average of $21.01 a share and its 50-day moving average of $21.11 a share with huge volume.

Traders should look for long-biased trades in Akorn, as long as it's trending above some near-term support at $20, and then once it breaks out above some key resistance levels at $22.62 to $23.71 with volume near or above 1.63 million shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next key resistance levels at its 200-day moving average of $25.84 a share to $26.32 a share.

Yadkin Financial

  • Wednesday's Volume: 1.16 million
  • Three-Month Average Volume: 264,490
  • Volume % Change: 367%

From a technical perspective, Yadkin Financial (YDKN) spiked sharply higher and broke out into new 52-week-high territory above previous resistance at $34.88 to $35.07 with strong volume. Market players should now look for a continuation move higher if this uptrend remains intact.

Traders should look for long-biased trades in Yadkin Financial, as long as it's trending above its 20-day moving average of $32.68 a share, and then once it clears its new 52-week high of $35.24 a share with volume near or above 264,490 shares. If that move gets started soon, then this stock will set up to make a run at $40 to $45 a share.

Kite Pharma

  • Wednesday's Volume: 6.98 million
  • Three-Month Average Volume: 1.04 million
  • Volume % Change: 622%

From a technical perspective, Kite Pharma (KITE) spiked sharply higher and broke out into new 52-week-high territory above $72.50 with monster upside volume flows.

Traders should look for long-biased trades in Kite Pharma, as long as it's trending above $72.50, and then once it clears its new 52-week high of $80.82 a share with volume near or above 1.04 million shares. If that move gets started soon, then this stock will set up to make a run at its next key resistance levels at $85 to $90 a share.

This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Stocks

12 Stocks That Make Up the GLUM Index

12 Stocks That Make Up the GLUM Index

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Worth a Stunning $6.6 Trillion, Tech Stocks Have Taken Over the Market

Worth a Stunning $6.6 Trillion, Tech Stocks Have Taken Over the Market

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Here's Why Snap Shares Climbed Monday

Here's Why Snap Shares Climbed Monday